| cellular ketone metabolic process | GO:0042180 | 80 | 0.107 | |
| post embryonic development | GO:0009791 | 2 | 0.087 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.078 | |
| amine metabolic process | GO:0009308 | 44 | 0.070 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.068 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.061 | |
| nervous system development | GO:0007399 | 293 | 0.059 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.057 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.057 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.055 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.055 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.051 | |
| segmentation | GO:0035282 | 4 | 0.049 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.048 | |
| lipid metabolic process | GO:0006629 | 381 | 0.047 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.047 | |
| organ formation | GO:0048645 | 3 | 0.047 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.045 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.044 | |
| locomotory behavior | GO:0007626 | 1 | 0.043 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.042 | |
| cell development | GO:0048468 | 328 | 0.042 | |
| cell morphogenesis | GO:0000902 | 296 | 0.041 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.041 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.040 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.040 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.039 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.039 | |
| neuron fate commitment | GO:0048663 | 2 | 0.038 | |
| forelimb morphogenesis | GO:0035136 | 4 | 0.038 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.038 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.037 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.037 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.037 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.037 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.037 | |
| female gamete generation | GO:0007292 | 2 | 0.036 | |
| oogenesis | GO:0048477 | 2 | 0.036 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.036 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.036 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.036 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.035 | |
| regulation of locomotion | GO:0040012 | 329 | 0.035 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.035 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.035 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.035 | |
| system process | GO:0003008 | 349 | 0.035 | |
| forebrain regionalization | GO:0021871 | 3 | 0.034 | |
| cardiovascular system development | GO:0072358 | 262 | 0.034 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.033 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.033 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.033 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.033 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.033 | |
| organ morphogenesis | GO:0009887 | 147 | 0.032 | |
| epithelium development | GO:0060429 | 227 | 0.032 | |
| cell adhesion | GO:0007155 | 325 | 0.032 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.032 | |
| regulation of cell motility | GO:2000145 | 299 | 0.032 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.032 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.032 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.031 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.031 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.031 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.031 | |
| positive regulation of tooth mineralization | GO:0070172 | 2 | 0.031 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.031 | |
| regulation of protein localization | GO:0032880 | 296 | 0.031 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.031 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.030 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.030 | |
| circulatory system development | GO:0072359 | 262 | 0.030 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.030 | |
| canonical wnt signaling pathway involved in mesenchymal stem cell differentiation | GO:0044338 | 2 | 0.030 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.030 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.030 | |
| positive regulation of aldosterone metabolic process | GO:0032346 | 2 | 0.030 | |
| regulation of cell migration | GO:0030334 | 289 | 0.030 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.030 | |
| hindbrain development | GO:0030902 | 3 | 0.029 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.029 | |
| immune response | GO:0006955 | 307 | 0.029 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.029 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.029 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.029 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.029 | |
| cell fate determination | GO:0001709 | 3 | 0.029 | |
| positive regulation of transport | GO:0051050 | 336 | 0.029 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.029 | |
| protein ubiquitination | GO:0016567 | 314 | 0.028 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.028 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.028 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.028 | |
| generation of neurons | GO:0048699 | 152 | 0.028 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.028 | |
| regulation of cytokine production | GO:0001817 | 232 | 0.028 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.028 | |
| neuron differentiation | GO:0030182 | 138 | 0.027 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.027 | |
| biological adhesion | GO:0022610 | 331 | 0.027 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.027 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.027 | |
| single organism cellular localization | GO:1902580 | 332 | 0.027 | |
| embryonic forelimb morphogenesis | GO:0035115 | 4 | 0.027 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.027 | |
| protein catabolic process | GO:0030163 | 325 | 0.027 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.027 | |
| cell projection organization | GO:0030030 | 252 | 0.027 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.026 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.026 | |
| immune system development | GO:0002520 | 195 | 0.026 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.026 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.026 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.026 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.026 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.026 | |
| skeletal system development | GO:0001501 | 79 | 0.026 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.026 | |
| vasculature development | GO:0001944 | 181 | 0.025 | |
| nerve development | GO:0021675 | 4 | 0.025 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.025 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.025 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.025 | |
| cardiac right ventricle morphogenesis | GO:0003215 | 3 | 0.025 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.025 | |
| canonical wnt signaling pathway involved in osteoblast differentiation | GO:0044339 | 2 | 0.025 | |
| secretion by cell | GO:0032940 | 226 | 0.025 | |
| regulation of secretion | GO:0051046 | 194 | 0.025 | |
| regeneration | GO:0031099 | 4 | 0.025 | |
| defense response | GO:0006952 | 315 | 0.025 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.025 | |
| motor neuron axon guidance | GO:0008045 | 2 | 0.025 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.025 | |
| positive regulation of epithelial cell proliferation involved in wound healing | GO:0060054 | 3 | 0.025 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.025 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.025 | |
| regulation of cell development | GO:0060284 | 161 | 0.024 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.024 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.024 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.024 | |
| negative regulation of male gonad development | GO:2000019 | 1 | 0.024 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.024 | |
| mapk cascade | GO:0000165 | 288 | 0.024 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.024 | |
| cranial nerve development | GO:0021545 | 4 | 0.024 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.024 | |
| chromatin organization | GO:0006325 | 351 | 0.024 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.024 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.024 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.024 | |
| neurogenesis | GO:0022008 | 169 | 0.024 | |
| dermatome development | GO:0061054 | 3 | 0.024 | |
| oxidation reduction process | GO:0055114 | 396 | 0.024 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.023 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.023 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.023 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.023 | |
| canonical wnt signaling pathway involved in cardiac muscle cell fate commitment | GO:0061317 | 3 | 0.023 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.023 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.023 | |
| sex determination | GO:0007530 | 3 | 0.023 | |
| protein localization to organelle | GO:0033365 | 280 | 0.023 | |
| positive regulation of glucocorticoid biosynthetic process | GO:0031948 | 1 | 0.023 | |
| single organism membrane organization | GO:0044802 | 268 | 0.023 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.023 | |
| cytokine production | GO:0001816 | 247 | 0.023 | |
| positive regulation of hormone biosynthetic process | GO:0046886 | 4 | 0.023 | |
| positive regulation of cortisol biosynthetic process | GO:2000066 | 1 | 0.023 | |
| neuroendocrine cell differentiation | GO:0061101 | 2 | 0.023 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.022 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.022 | |
| response to lipid | GO:0033993 | 206 | 0.022 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.022 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.022 | |
| inorganic cation transmembrane transport | GO:0098662 | 194 | 0.022 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.022 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.022 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.022 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.022 | |
| cation transport | GO:0006812 | 331 | 0.022 | |
| gtp catabolic process | GO:0006184 | 237 | 0.022 | |
| compound eye development | GO:0048749 | 1 | 0.022 | |
| histone modification | GO:0016570 | 251 | 0.021 | |
| regulation of protein transport | GO:0051223 | 213 | 0.021 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.021 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.021 | |
| memory | GO:0007613 | 3 | 0.021 | |
| secretion | GO:0046903 | 254 | 0.021 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.021 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.021 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.021 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.021 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.021 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.021 | |
| epidermis morphogenesis | GO:0048730 | 3 | 0.020 | |
| hemopoiesis | GO:0030097 | 180 | 0.020 | |
| growth | GO:0040007 | 202 | 0.020 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.020 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.020 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.020 | |
| head development | GO:0060322 | 108 | 0.020 | |
| negative regulation of testicular blood vessel morphogenesis | GO:0061369 | 1 | 0.020 | |
| membrane organization | GO:0061024 | 292 | 0.020 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.020 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.020 | |
| regulation of dermatome development | GO:0061183 | 3 | 0.020 | |
| spermatid differentiation | GO:0048515 | 4 | 0.020 | |
| regulation of growth | GO:0040008 | 165 | 0.020 | |
| regulation of cardioblast differentiation | GO:0051890 | 4 | 0.020 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.020 | |
| rhythmic behavior | GO:0007622 | 2 | 0.020 | |
| positive regulation of odontogenesis | GO:0042482 | 3 | 0.020 | |
| fatty acid metabolic process | GO:0006631 | 115 | 0.019 | |
| chemical homeostasis | GO:0048878 | 306 | 0.019 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.019 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.019 | |
| chromatin modification | GO:0016568 | 298 | 0.019 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.019 | |
| regulation of male gonad development | GO:2000018 | 4 | 0.019 | |
| positive regulation of monocyte chemotactic protein 1 production | GO:0071639 | 3 | 0.019 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.019 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.019 | |
| inorganic ion transmembrane transport | GO:0098660 | 231 | 0.019 | |
| blood vessel development | GO:0001568 | 172 | 0.019 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.019 | |
| inner ear morphogenesis | GO:0042472 | 4 | 0.019 | |
| aortic valve development | GO:0003176 | 3 | 0.019 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.019 | |
| mating | GO:0007618 | 1 | 0.019 | |
| cardiac muscle cell contraction | GO:0086003 | 4 | 0.019 | |
| dephosphorylation | GO:0016311 | 209 | 0.019 | |
| metencephalon development | GO:0022037 | 2 | 0.018 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.018 | |
| cell cell signaling | GO:0007267 | 155 | 0.018 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.018 | |
| cerebellum development | GO:0021549 | 2 | 0.018 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.018 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.018 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.018 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.018 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.018 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 4 | 0.018 | |
| central nervous system development | GO:0007417 | 123 | 0.018 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.018 | |
| cell growth | GO:0016049 | 160 | 0.018 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.018 | |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.018 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.018 | |
| protein maturation | GO:0051604 | 233 | 0.018 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.018 | |
| spermatid development | GO:0007286 | 4 | 0.018 | |
| oocyte differentiation | GO:0009994 | 2 | 0.018 | |
| cation transmembrane transport | GO:0098655 | 238 | 0.018 | |
| maintenance of location | GO:0051235 | 112 | 0.018 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.018 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.018 | |
| hindlimb morphogenesis | GO:0035137 | 2 | 0.018 | |
| circadian behavior | GO:0048512 | 2 | 0.018 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.018 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.018 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.017 | |
| extraocular skeletal muscle development | GO:0002074 | 1 | 0.017 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.017 | |
| pituitary gland development | GO:0021983 | 2 | 0.017 | |
| intracellular protein transport | GO:0006886 | 270 | 0.017 | |
| positive regulation of cell migration | GO:0030335 | 172 | 0.017 | |
| oxidative stress induced premature senescence | GO:0090403 | 3 | 0.017 | |
| photoreceptor cell differentiation | GO:0046530 | 2 | 0.017 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 185 | 0.017 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.017 | |
| anterior posterior axis specification embryo | GO:0008595 | 2 | 0.017 | |
| somitogenesis | GO:0001756 | 2 | 0.017 | |
| metal ion transport | GO:0030001 | 272 | 0.017 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.017 | |
| actin filament based process | GO:0030029 | 224 | 0.017 | |
| tongue development | GO:0043586 | 1 | 0.017 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.017 | |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.017 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.017 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 2 | 0.017 | |
| urogenital system development | GO:0001655 | 65 | 0.017 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.017 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.017 | |
| neuron projection development | GO:0031175 | 106 | 0.017 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.017 | |
| paramesonephric duct development | GO:0061205 | 2 | 0.016 | |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.016 | |
| oocyte development | GO:0048599 | 1 | 0.016 | |
| negative regulation of cell migration | GO:0030336 | 102 | 0.016 | |
| neurotransmitter secretion | GO:0007269 | 4 | 0.016 | |
| myoblast fusion | GO:0007520 | 1 | 0.016 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.016 | |
| endomembrane system organization | GO:0010256 | 196 | 0.016 | |
| startle response | GO:0001964 | 3 | 0.016 | |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.016 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.016 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.016 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.016 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.016 | |
| transmembrane transport | GO:0055085 | 399 | 0.016 | |
| tripartite regional subdivision | GO:0007351 | 2 | 0.016 | |
| stem cell differentiation | GO:0048863 | 93 | 0.016 | |
| response to wounding | GO:0009611 | 168 | 0.016 | |
| thymus development | GO:0048538 | 3 | 0.016 | |
| positive regulation of dermatome development | GO:0061184 | 3 | 0.016 | |
| limbic system development | GO:0021761 | 3 | 0.016 | |
| cell differentiation in spinal cord | GO:0021515 | 1 | 0.016 | |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.016 | |
| androgen biosynthetic process | GO:0006702 | 3 | 0.016 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.016 | |
| single organism cell adhesion | GO:0098602 | 179 | 0.016 | |
| negative regulation of transport | GO:0051051 | 176 | 0.016 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.016 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.016 | |
| protein processing | GO:0016485 | 226 | 0.015 | |
| neuron development | GO:0048666 | 113 | 0.015 | |
| innate immune response | GO:0045087 | 178 | 0.015 | |
| embryo development | GO:0009790 | 123 | 0.015 | |
| brain development | GO:0007420 | 97 | 0.015 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.015 | |
| mesonephric duct development | GO:0072177 | 3 | 0.015 | |
| positive regulation of insulin like growth factor receptor signaling pathway | GO:0043568 | 4 | 0.015 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.015 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.015 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.015 | |
| positive regulation of aldosterone biosynthetic process | GO:0032349 | 2 | 0.015 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.015 | |
| gtp metabolic process | GO:0046039 | 239 | 0.015 | |
| protein targeting | GO:0006605 | 187 | 0.015 | |
| hair follicle morphogenesis | GO:0031069 | 2 | 0.015 | |
| positive regulation of synaptic transmission | GO:0050806 | 4 | 0.015 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.015 | |
| microtubule based process | GO:0007017 | 210 | 0.015 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 4 | 0.015 | |
| tissue regeneration | GO:0042246 | 3 | 0.015 | |
| cell division | GO:0051301 | 168 | 0.015 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.015 | |
| positive regulation of steroid hormone biosynthetic process | GO:0090031 | 2 | 0.015 | |
| ion homeostasis | GO:0050801 | 230 | 0.015 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.015 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.015 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.015 | |
| proteasomal protein catabolic process | GO:0010498 | 176 | 0.015 | |
| cloacal septation | GO:0060197 | 1 | 0.015 | |
| male genitalia development | GO:0030539 | 1 | 0.014 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.014 | |
| embryonic camera type eye development | GO:0031076 | 2 | 0.014 | |
| protein acylation | GO:0043543 | 138 | 0.014 | |
| negative regulation of growth | GO:0045926 | 97 | 0.014 | |
| response to fungus | GO:0009620 | 4 | 0.014 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.014 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.014 | |
| negative regulation of cell motility | GO:2000146 | 104 | 0.014 | |
| regulation of immune response | GO:0050776 | 201 | 0.014 | |
| regulation of cell growth | GO:0001558 | 135 | 0.014 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.014 | |
| nuclear transport | GO:0051169 | 179 | 0.014 | |
| protein localization to membrane | GO:0072657 | 160 | 0.014 | |
| neural tube formation | GO:0001841 | 3 | 0.014 | |
| specification of organ identity | GO:0010092 | 3 | 0.014 | |
| negative regulation of gliogenesis | GO:0014014 | 3 | 0.014 | |
| primary neural tube formation | GO:0014020 | 3 | 0.014 | |
| regulation of gtpase activity | GO:0043087 | 180 | 0.014 | |
| response to other organism | GO:0051707 | 261 | 0.014 | |
| cellular response to lipid | GO:0071396 | 127 | 0.014 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.014 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.014 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.014 | |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.014 | |
| negative regulation of phosphatidylinositol 3 kinase signaling | GO:0014067 | 4 | 0.014 | |
| heart development | GO:0007507 | 95 | 0.014 | |
| regulation of synaptic plasticity | GO:0048167 | 3 | 0.014 | |
| glycoprotein metabolic process | GO:0009100 | 110 | 0.014 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.014 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.014 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.014 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.014 | |
| osteoblast differentiation | GO:0001649 | 92 | 0.014 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 2 | 0.014 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 186 | 0.014 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 186 | 0.014 | |
| cell activation | GO:0001775 | 213 | 0.014 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.014 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 156 | 0.014 | |
| developmental programmed cell death | GO:0010623 | 3 | 0.014 | |
| tissue migration | GO:0090130 | 119 | 0.014 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.014 | |
| response to cytokine | GO:0034097 | 232 | 0.014 | |
| monovalent inorganic cation transport | GO:0015672 | 128 | 0.014 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.014 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.014 | |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.013 | |
| protein autophosphorylation | GO:0046777 | 123 | 0.013 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.013 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.013 | |
| aortic valve morphogenesis | GO:0003180 | 3 | 0.013 | |
| reproductive process | GO:0022414 | 106 | 0.013 | |
| regulation of ras gtpase activity | GO:0032318 | 128 | 0.013 | |
| tube development | GO:0035295 | 125 | 0.013 | |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.013 | |
| tube closure | GO:0060606 | 3 | 0.013 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 3 | 0.013 | |
| canonical wnt signaling pathway involved in negative regulation of apoptotic process | GO:0044336 | 2 | 0.013 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.013 | |
| protein o linked glycosylation via threonine | GO:0018243 | 4 | 0.013 | |
| embryonic hindlimb morphogenesis | GO:0035116 | 2 | 0.013 | |
| ventral spinal cord development | GO:0021517 | 1 | 0.013 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.013 | |
| organic acid biosynthetic process | GO:0016053 | 97 | 0.013 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.013 | |
| blood circulation | GO:0008015 | 113 | 0.013 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.013 | |
| copulation | GO:0007620 | 1 | 0.013 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.013 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.013 | |
| post embryonic organ development | GO:0048569 | 1 | 0.013 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 2 | 0.013 | |
| muscle cell fate commitment | GO:0042693 | 4 | 0.013 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.013 | |
| cell proliferation in forebrain | GO:0021846 | 1 | 0.013 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 3 | 0.013 | |
| regulation of odontogenesis | GO:0042481 | 4 | 0.013 | |
| dna repair | GO:0006281 | 198 | 0.013 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.013 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.013 | |
| organophosphate biosynthetic process | GO:0090407 | 163 | 0.013 | |
| regulation of meiotic cell cycle | GO:0051445 | 4 | 0.013 | |
| neurological system process | GO:0050877 | 163 | 0.013 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.013 | |
| mesenchyme development | GO:0060485 | 59 | 0.013 | |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.013 | |
| limb bud formation | GO:0060174 | 1 | 0.013 | |
| protein oligomerization | GO:0051259 | 173 | 0.013 | |
| single organismal cell cell adhesion | GO:0016337 | 148 | 0.013 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.013 | |
| lipid catabolic process | GO:0016042 | 84 | 0.013 | |
| mesenchymal cell differentiation | GO:0048762 | 52 | 0.013 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 187 | 0.013 | |
| somatic muscle development | GO:0007525 | 1 | 0.013 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.013 | |
| reactive nitrogen species metabolic process | GO:2001057 | 3 | 0.013 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.012 | |
| blastocyst development | GO:0001824 | 3 | 0.012 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.012 | |
| positive regulation of secretion | GO:0051047 | 116 | 0.012 | |
| angiogenesis | GO:0001525 | 147 | 0.012 | |
| wnt signaling pathway involved in wound healing spreading of epidermal cells | GO:0035659 | 1 | 0.012 | |
| hormone secretion | GO:0046879 | 65 | 0.012 | |
| protein secretion | GO:0009306 | 98 | 0.012 | |
| cellular homeostasis | GO:0019725 | 196 | 0.012 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.012 | |
| cell substrate adhesion | GO:0031589 | 132 | 0.012 | |
| regulation of protein secretion | GO:0050708 | 86 | 0.012 | |
| rna processing | GO:0006396 | 255 | 0.012 | |
| behavior | GO:0007610 | 112 | 0.012 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.012 | |
| glial cell migration | GO:0008347 | 4 | 0.012 | |
| regulation of transmembrane transporter activity | GO:0022898 | 74 | 0.012 | |
| pericardium development | GO:0060039 | 2 | 0.012 | |
| embryonic eye morphogenesis | GO:0048048 | 2 | 0.012 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.012 | |
| carboxylic acid biosynthetic process | GO:0046394 | 97 | 0.012 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.012 | |
| sensory perception of smell | GO:0007608 | 2 | 0.012 | |
| renal system development | GO:0072001 | 63 | 0.012 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.012 | |
| response to growth factor | GO:0070848 | 205 | 0.012 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.012 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.012 | |
| neural tube closure | GO:0001843 | 3 | 0.012 | |
| sensory perception of pain | GO:0019233 | 4 | 0.012 | |
| regulation of ion transport | GO:0043269 | 189 | 0.012 | |
| regulation of intracellular protein transport | GO:0033157 | 123 | 0.012 | |
| ossification | GO:0001503 | 121 | 0.012 | |
